Guggenheim Maintains Buy on Bruker, Raises Price Target to $72

Benzinga Newsdesk www.benzinga.com Positive 83.5%

Neg 0% Neu 0% Pos 83.5%

Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $70 to $72.

Comments

No comments yet. Be the first!